21 CFR 606.100(c) citations
FDA investigators cited 21 CFR 606.100(c) 417 times at 313 facilities in the inspection citations FDA publishes, most recently in an inspection that ended Apr 14, 2026. A citation is an observation listed on Form FDA 483 at the end of an inspection; it is not a final agency decision.
Citations by fiscal year
| FDA fiscal year | Citations |
|---|---|
| 2026 | 4 |
| 2025 | 21 |
| 2024 | 5 |
| 2023 | 7 |
| 2022 | 10 |
| 2021 | 1 |
| 2020 | 2 |
| 2019 | 14 |
| 2018 | 7 |
| 2017 | 25 |
Recent citations
The latest inspections that cited this section. Facility names link to each facility's FDA record.
| Inspection ended | Facility | Country | Observation |
|---|---|---|---|
| Apr 14, 2026 | Biomat USA Inc | United States | Failure to perform a thorough investigation and make a record of the conclusions and follow-up of an unexplained discrepancy. |
| Jan 13, 2026 | The Blood Connection - Lexington | United States | Failure to perform a thorough investigation and make a record of the conclusions and follow-up of an unexplained discrepancy. |
| Dec 5, 2025 | BioLife Plasma Services LP | United States | Failure to perform a thorough investigation and make a record of the conclusions and follow-up of an unexplained discrepancy. |
| Nov 6, 2025 | Biomat USA Inc | United States | Failure to perform a thorough investigation and make a record of the conclusions and follow-up of an unexplained discrepancy. |
| Aug 29, 2025 | Central California Blood Center | United States | Failure to perform a thorough investigation and make a record of the conclusions and follow-up of an unexplained discrepancy. |
| Aug 29, 2025 | Creative Testing Solutions | United States | Failure to perform a thorough investigation and make a record of the conclusions and follow-up of an unexplained discrepancy. |
| Aug 8, 2025 | VA Boston Healthcare System | United States | Failure to perform a thorough investigation and make a record of the conclusions and follow-up of an unexplained discrepancy. |
| Jul 30, 2025 | Reading Hospital | United States | Failure to perform a thorough investigation and make a record of the conclusions and follow-up of an unexplained discrepancy. |
| Jul 1, 2025 | Harper University Hospital | United States | Failure to perform a thorough investigation of an unexplained discrepancy. |
| Jun 12, 2025 | Vitalant | United States | All records pertinent to a lot or unit were not reviewed before the release or distribution of a lot or unit of final product. |
| Jun 12, 2025 | Vitalant | United States | Failure to perform a thorough investigation and make a record of the conclusions and follow-up of an unexplained discrepancy and a failure of a lot or unit to meet any of its specifications. |
| May 27, 2025 | Blood Connection, Inc. (The) | United States | Failure to perform a thorough investigation of an unexplained discrepancy. |
| May 9, 2025 | Ascension Saint John Medical Center | United States | All records pertinent to a lot or unit were not reviewed before the release or distribution of a lot or unit of final product. |
| May 9, 2025 | Ascension Saint John Medical Center | United States | Failure to perform a thorough investigation and make a record of the conclusions and follow-up of an unexplained discrepancy and a failure of a lot or unit to meet any of its specifications. |
| May 1, 2025 | Department Of The Army Blanchfield Army Community Hospital | United States | Failure to perform a thorough investigation of an unexplained discrepancy. |
| Apr 24, 2025 | Baptist Health Deaconess Madisonville Inc | United States | Failure to perform a thorough investigation of an unexplained discrepancy. |
| Apr 14, 2025 | Lifesouth Community Blood Centers - Montgomery Region | United States | Failure to perform a thorough investigation and make a record of the conclusions and follow-up of an unexplained discrepancy. |
| Apr 1, 2025 | University Medical Center Of Southern Nevada | United States | Failure to perform a thorough investigation and make a record of the conclusions and follow-up of an unexplained discrepancy and a failure of a lot or unit to meet any of its specifications. |
| Mar 27, 2025 | Department Of Defense - Air Force, 99Th Medical Group | United States | Failure to perform a thorough investigation of an unexplained discrepancy and a failure of a lot or unit to meet any of its specifications. |
| Mar 26, 2025 | Lifesouth Community Blood Centers Inc. - East Alabama Region | United States | Failure to perform a thorough investigation and make a record of the conclusions and follow-up of an unexplained discrepancy. |
| Feb 28, 2025 | Ioannis Lougaris VA Medical Center Laboratory Service (113) Blood Bank | United States | Failure to make a record of the conclusions and follow-up of an unexplained discrepancy and a failure of a lot or unit to meet any of its specifications. |
| Feb 7, 2025 | Vitalant | United States | All records pertinent to a lot or unit were not reviewed before the release or distribution of a lot or unit of final product. |
| Feb 7, 2025 | Vitalant | United States | Failure to perform a thorough investigation of an unexplained discrepancy and a failure of a lot or unit to meet any of its specifications. |
| Jan 31, 2025 | Suncoast Communities Blood Bank, Inc. | United States | Failure to perform a thorough investigation of an unexplained discrepancy. |
| Jan 9, 2025 | Biomat USA, Inc. | United States | Failure to perform a thorough investigation of an unexplained discrepancy and a failure of a lot or unit to meet any of its specifications. |
Search more
Search every Form 483 citation by company with the FDA 483 search, see all frequently cited CFR sections, or check one supplier with the free FDA compliance check.